Direkt zum Inhalt
Merck
  • Ablation of proximal tubular suppressor of cytokine signaling 3 enhances tubular cell cycling and modifies macrophage phenotype during acute kidney injury.

Ablation of proximal tubular suppressor of cytokine signaling 3 enhances tubular cell cycling and modifies macrophage phenotype during acute kidney injury.

Kidney international (2014-01-10)
Nathan Susnik, Inga Sörensen-Zender, Song Rong, Sibylle von Vietinghoff, Xia Lu, Isabelle Rubera, Michel Tauc, Christine S Falk, Warren S Alexander, Anette Melk, Herrmann Haller, Roland Schmitt
ZUSAMMENFASSUNG

Suppressor of cytokine signaling 3 (SOCS-3) is an important intracellular negative regulator of several signaling pathways. We found that SOCS-3 is highly expressed in renal proximal tubules during acute kidney injury. To test the impact of this, conditional proximal tubular knockout mice (SOCS-3(sglt2Δ/sglt2Δ)) were created. These mice had better kidney function than their wild-type counterparts in aristolochic acid nephropathy and after ischemia/reperfusion injury. Kidneys of these knockout mice showed significantly more proximal tubular cell proliferation during the repair phase. A direct effect of SOCS-3 on tubular cell cycling was demonstrated by in vitro experiments showing a JAK/STAT pathway-dependent antimitotic effect of SOCS-3. Furthermore, acute damaged kidneys of the knockout mice contained increased numbers of F4/80(+) cells. Phenotypic analysis of these F4/80(+) cells indicated a polarization from classically activated to alternatively activated macrophages. In vitro, SOCS-3-overexpressing renal epithelial cells directly induced classical activation in cocultured macrophages, supporting the observed in vivo phenomenon. Thus, upregulation of SOCS-3 in stressed proximal tubules plays an important role during acute kidney injury by inhibition of reparative proliferation and by modulation of the macrophage phenotype. Antagonizing SOCS-3 could have therapeutic potential for acute kidney injury.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Harnstoff, powder, BioReagent, for molecular biology, suitable for cell culture
Supelco
Harnstoff, 8 M (after reconstitution with 16 mL high purity water)
Sigma-Aldrich
Harnstoff -Lösung, BioUltra, ~8 M in H2O
Sigma-Aldrich
Fluorescein, for fluorescence, free acid
Sigma-Aldrich
Harnstoff, BioXtra, pH 7.5-9.5 (20 °C, 5 M in H2O)
Sigma-Aldrich
Harnstoff, ACS reagent, 99.0-100.5%
Sigma-Aldrich
Harnstoff, BioUltra, for molecular biology, 99% (T)
Sigma-Aldrich
Harnstoff, suitable for electrophoresis
Sigma-Aldrich
Azodicarbonsäure-diethylester -Lösung, purum, ~40% in toluene (H-NMR)
USP
Harnstoff, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Harnstoff, meets USP testing specifications
Sigma-Aldrich
Harnstoff -Lösung, 40 % (w/v) in H2O
Sigma-Aldrich
Harnstoff, ReagentPlus®, ≥99.5%, pellets
Sigma-Aldrich
Harnstoff, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.0-100.5%, 99.0-101.0% (calc. on dry substance)
Fluorescein, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Harnstoff, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99%
Millipore
Harnstoff -Lösung, suitable for microbiology, 40% in H2O
Supelco
Harnstoff, analytical standard
Sigma-Aldrich
Harnstoff-12C, 99.9 atom % 12C
Sigma-Aldrich
Oncostatin M from mouse, BioReagent, ≥97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture
Harnstoff, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
MISSION® esiRNA, targeting human LAMC2
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Csf2
Sigma-Aldrich
MISSION® esiRNA, targeting human CSF2